Don’t forget you can visit MyAlerts to manage your alerts at any time.
Regulation and litigation surrounding food and drug safety violations and practices before the U.S. FDA and courts.
By Dan Clark | July 15, 2019
Many in-house counsel, according to the report, have growing concerns over cannabis-related litigation.
1 minute read
By Xiumei Dong | June 18, 2019
Kate Spelman has returned to Jenner & Block's Los Angeles office as a partner in its complex commercial litigation practice.
1 minute read
By Cheryl Miller | May 30, 2019
Welcome to Higher Law -- our weekly roundup of news and analysis for cannabis industry lawyers. Thanks for reading!
1 minute read
By Steve Schain | May 2, 2019
With the FDA "locked and loaded," and billions of annual sales and "deal flow capital" hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims.
1 minute read
By Ian A. Stewart | May 2, 2019
CBD risk management requires constant education and vigilance to stay abreast of an area of the law changing more rapidly than any other in recent history.
1 minute read
By Justin Parafinczuk and Marcus Susen | May 1, 2019
In March 2019 the U.S. Food and Drug Administration issued a statement from Commissioner Scott Gottlieb and Jeff Shuren, its director of the Center for Devices and Radiological Health, on the evaluation of materials in medical devices to address potential safety issues. It was an important step in improving medical device safety.
1 minute read
By Zach Schlein | April 30, 2019
U.S. Magistrate Judge William Matthewman denied the department's request in an order issued Monday. The department had sought to preclude Kuehne Davis Law litigators Benedict "Ben" Kuehne and Michael Davis from continuing to represent dietary supplement company Blackstone Labs and its CEO, Phillip Braun.
1 minute read
By Christopher Ezold | April 11, 2019
A question that investors frequently ask of emerging growth life sciences companies is whether they have considered how to monetize the data they will inevitably collect in the development, marketing and sale of their service or product.
1 minute read
By Cheryl Miller | March 21, 2019
We're closely following the big hemp case in the Ninth Circuit, where a Hogan Lovells team—including Neal Katyal—just made their appearances. Plus: Squire Patton Boggs has a new cannabis lobbying client. Scroll down for Who Got the Work, and more. Thanks for reading Higher Law!
1 minute read
By Matthew B. Andersen | February 25, 2019
In the ever-changing regulatory landscape that alcohol manufacturers must navigate, the regulations imposed by the U.S. Food and Drug Administration (FDA) are often overlooked.
1 minute read
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS